House Majority Leader Steve Scalise, R-La., is hammering Democrats over the partial government shutdown as its effects begin to hit millions of…
Gilead Sciences (NASDAQ:GILD) will acquire cancer immunotherapy partner Arcellx (NASDAQ:ACLX) in a deal worth up to US$7.8 billion, moving to take full…
